KAN LLC, part of KAN Development Group (both based in Kyiv), saw a 10.5-fold rise in net profit in Q2 2018, to UAH 24.8 million. According to an annual report of the company posted in the information disclosure system of the National Commission for Securities and the Stock Market, net revenue in H1 2018 grew 1.6-fold, to UAH 79.4 million, and uncovered loss fell by 6%, to UAH 385.9 million.
Noncurrent liabilities fell by 1.6%, to UAH 579.2 million, and current liabilities decreased 32%, to UAH 277.9 million, total bills receivable narrowed by 42.4%, to UAH 39.9 million.
KAN Development LLC was established in 2001. As of July 2018, the participant of the limited liability company was Deverte Holding GmbH (Austria, 100%).
Biopharma, a blood products maker, plans to boost suppliers of its products to the traditional markets for the company and actively develop new ones – India, African countries, Biopharma Group President Kostiantyn Yefymenko has said in an interview with Interfax-Ukraine. The group plans to boost sales in Ukraine and supplies to Belarus, Kazakhstan, Uzbekistan, Azerbaijan, Armenia, Tajikistan, Kyrgyzstan and Georgia.
“At the same time, the most promising for us is the Indian market, and after it – Africa, where we will intensively increase our presence,” Yefymenko said.
Commenting on plans for expansion of activities in foreign pharmaceutical markets, he said that currently Biopharma “does not strongly focus on the EU countries” because of the conservatism of this market, although it delivers its drugs, in particular probiotics, to some European countries – Slovakia and the Czech Republic.
Biopharma is one of the ten largest Ukrainian producers of medicines. It produces more than 20 immunobiological preparations from donor blood, preparations obtained by recombinant DNA technology and probiotics.
The Poltava international airport has serviced the first flight after reconstruction, First Deputy Head of Poltava Regional Administration Andriy Pesotsky has written on his Facebook page. “We have serviced the first flight after the reconstruction of the airport. Citizens of the United States, Canada, China and Europe arrived. They are not simply tourists, but bloggers and all those interested in aviation… I am proud that we have set the airport in order and now we can service flights both from other cities, and foreign flights,” he said.
According to the regional news portal Poltava News, the first flight of the airport is domestic, and a few dozen of foreign tourists flew from Zaporizhia by Yak-40 plane. As reported, on January 31, 2017, Poltava Regional Council adopted a program to develop and support the Poltava airport for 2017-2020 with the total cost of UAH 351 million. On December 20, 2017, the Cabinet of Ministers of Ukraine granted the status of the international airport to the Poltava airport.
Biopharma, a blood products maker, plans to bring tetanus immune globulin (TIG) to the market by the end of 2019, Biopharma Group President Kostiantyn Yefymenko has said in an interview with Interfax-Ukraine. “Taking into account the country’s needs, we are working on the specific tetanus immune globulin. We hope that we would be able to bring it to the market by late 2019,” he said.
Biopharma is one of the ten largest Ukrainian producers of medicines. It produces more than 20 immunobiological preparations from donor blood, preparations obtained by recombinant DNA technology and probiotics.
The share of non-performing loans (NPL) in the total volume of loans in Ukraine in June 2018 fell by 0.37 percentage points (p.p.), to 55.68% as of July 1, 2018, according to the National Bank of Ukraine (NBU). The central bank said that in particular, the share of NPL in the loan portfolio of state-owned banks fell by 0.77 p.p., to 71.06%, including a 0.44 p.p. fall in PrivatBank, to 84.64%, in portfolios of foreign bank groups – by 0.29 p.p., to 42.54% and banks with private capital – by 0.96 p.p., to 24.09%.
The share of NPL in insolvent financial institutions grew by 10.92 p.p., to 69.3%.
The loan portfolio grew by 0.33% in June, to UAH 1.125 trillion. Since the start of the year, the share of NPL has grown by 1.13% and the portfolio has expanded by 3.09%. The share of troubled assets of the banking system, taking into account off-balance sheet liabilities, was 29.21% (0.12 p.p. down) as of July 1, 2018. It was 0.88 p.p. more than as of late 2017. The total troubled assets grew by 0.04% in June, to UAH 2.234 trillion, and by 1.6% since early 2018.
The NBU first published statistics for NPL meeting the requirements in resolution No. 351 dated June 30, 2016 on assessment of credit risks in March 2017. The resolution says that NPL notion as close as possible to the common notion in global practice “non-performing exposures/loans” (NPE/NPL). According to the new rules, NPL are loans overdue for over 90 days (30 for banks) or it is unlikely that the debt without seizing collateral can be collected.
One troy ounce=31.10 grams
